跳至主要内容
临床试验/2023-508413-16-00
2023-508413-16-00招募中2 期

OXYTAHANE - Oxygen therapy: Acute Treatment for paroxysmal dystonic or plegic attacks in alternating hemiplegia of childhood

Assistance Publique Hopitaux De Paris2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2024年3月27日最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
24
试验地点
2
主要终点
The primary outcome will be the proportion of motor attacks stopped 30 minutes after the beginning of motor symptoms over 5 weeks.

研究概览

简要总结

The aim of the study is to assess the effect of high-flow oxygen administration (against placebo) as an acute treatment of dystonic and plegic attacks

入排标准

年龄范围
0 years 至 65+ years(0-17 Years, 65+ Years, 18-64 Years)
接受健康志愿者

入选标准

  • Age > 1 year old
  • Patients able to administrate high-flow oxygen through a non rebreathing facial mask, either alone or with assistance
  • Patients with a diagnosis of AHC caused by ATP1A3 mutations presenting at least one dystonic or plegic attack per week lasting more than 30 minutes
  • Absence of long-term treatment or long-term treatment stable over the last month and during the duration of the trial
  • Patients able to give written informed consent
  • Affiliation to social insurance

排除标准

  • Inability for the patients and/or caregivers to follow the protocol (inability to read or understand the instructions, no access to smartphone or computer to fill the informatics patient’s form)
  • Patients with severe or uncontrolled obstructive or restrictive chronic respiratory disease (asthma, COPD, obesity, neuromuscular disease), acute systemic aggression (acute coronary syndrome, stroke, sepsis, head trauma) or congenital cardiopathy with a risk of hypercapnia following oxygen administration
  • Women that are pregnant (a negative pregnancy test is required for inclusion) or breath feeding
  • Patients involved in an other clinical trial

结局指标

主要结局

The primary outcome will be the proportion of motor attacks stopped 30 minutes after the beginning of motor symptoms over 5 weeks.

The primary outcome will be the proportion of motor attacks stopped 30 minutes after the beginning of motor symptoms over 5 weeks.

次要结局

未报告次要终点

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Pr Flamand-Roze

Scientific

Assistance Publique Hopitaux De Paris

研究点 (2)

Loading locations...

相似试验